What is Congenital Sucrase-Isomaltase Deficiency?
Congenital Sucrase-Isomaltase Deficiency (CSID) is a rare genetic disorder first discovered in 1960 by Weijers and colleagues.1 The disorder is caused by pathogenic mutations in the sucrase-isomaltase gene (SI).
It is a disease of the small intestine characterized primarily by a failure to metabolize sucrose for intestinal absorption.
- Weijers HA, van de Kamer JH, Mossel DA, Dicke WK. Diarrhoea caused by deficiency of sugar-splitting enzymes. Lancet. 1960;2(7145):296-297.
Order a FREE Breath Test
Do you have patients suffering with unresolved IBS-like symptoms including gas, bloating, diarrhea, and/or nausea? Could it be CSID? Order FREE Breath Test kits for your office.
Sucraid® is available by prescription only through one specialty pharmacy, US Bioservices at 1-833-800-0122.
Here are the steps for filling a prescription for Sucraid® from the specialty pharmacy:
- The physician must complete the Sucraid® Prescription Form and fax it to 1-866-850-9155
- The specialty pharmacy will contact the patient directly to schedule delivery of Sucraid®
- Sucraid® will be shipped to the patient’s home or the physician’s office
- For refill orders or any questions, call US Bioservices 1-833-800-0122
What is Sucraid®?
Sucraid® is the only FDA-approved enzyme replacement therapy indicated for the treatment of genetically determined sucrase deficiency, which is a part of Congenital Sucrase-Isomaltase Deficiency (CSID).
Sucraid® is an enzyme replacement therapy that facilitates the breakdown of sucrose (sugar) into monosaccharides for absorption by the small intestine. It has been shown to help alleviate the gastrointestinal (GI) symptoms associated with CSID, and, as a result, patients can maintain a more normal diet that includes sucrose-containing foods.